140 related articles for article (PubMed ID: 27040623)
1. Design, Synthesis, and Molecular Docking Studies of a Conjugated Thiadiazole-Thiourea Scaffold as Antituberculosis Agents.
Tatar E; Karakuş S; Küçükgüzel ŞG; Öktem Okullu S; Ünübol N; Kocagöz T; De Clercq E; Andrei G; Snoeck R; Pannecouque C; Kalaycı S; Şahin F; Sriram D; Yogeeswari P; Küçükgüzel İ
Biol Pharm Bull; 2016; 39(4):502-15. PubMed ID: 27040623
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of thiourea-based derivatives as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
Doğan ŞD; Gündüz MG; Doğan H; Krishna VS; Lherbet C; Sriram D
Eur J Med Chem; 2020 Aug; 199():112402. PubMed ID: 32417538
[TBL] [Abstract][Full Text] [Related]
3. Design of new phenothiazine-thiadiazole hybrids via molecular hybridization approach for the development of potent antitubercular agents.
Ramprasad J; Nayak N; Dalimba U
Eur J Med Chem; 2015 Dec; 106():75-84. PubMed ID: 26520841
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial and anti-biofilm activity of thiourea derivatives incorporating a 2-aminothiazole scaffold.
Stefanska J; Nowicka G; Struga M; Szulczyk D; Koziol AE; Augustynowicz-Kopec E; Napiorkowska A; Bielenica A; Filipowski W; Filipowska A; Drzewiecka A; Giliberti G; Madeddu S; Boi S; La Colla P; Sanna G
Chem Pharm Bull (Tokyo); 2015; 63(3):225-36. PubMed ID: 25757494
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Antimicrobial Activity and Molecular Docking of Novel Thiourea Derivatives Tagged with Thiadiazole, Imidazole and Triazine Moieties as Potential DNA Gyrase and Topoisomerase IV Inhibitors.
Hashem HE; Amr AEE; Nossier ES; Elsayed EA; Azmy EM
Molecules; 2020 Jun; 25(12):. PubMed ID: 32549386
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Biological Activities of Ethyl 2-(2-pyridylacetate) Derivatives Containing Thiourea, 1,2,4-triazole, Thiadiazole and Oxadiazole Moieties.
Szulczyk D; Tomaszewski P; Jóźwiak M; Kozioł AE; Lis T; Collu D; Iuliano F; Struga M
Molecules; 2017 Mar; 22(3):. PubMed ID: 28272311
[TBL] [Abstract][Full Text] [Related]
7. Antituberculosis agents. V. Synthesis, evaluation of in vitro antituberculosis activity and cytotoxicity of some 2-(5-nitro-2-furyl)-1,3,4-thiadiazole derivatives.
Foroumadi A; Asadipour A; Mirzaei M; Karimi J; Emami S
Farmaco; 2002 Sep; 57(9):765-9. PubMed ID: 12385528
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, docking, ADMET prediction, cytotoxicity and antimicrobial activity of oxathiadiazole derivatives.
Yadav M; Srivastava R; Naaz F; Singh RK
Comput Biol Chem; 2018 Dec; 77():226-239. PubMed ID: 30366286
[TBL] [Abstract][Full Text] [Related]
9. Antituberculosis agents II. Evaluation of in vitro antituberculosis activity and cytotoxicity of some 2-(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazole derivatives.
Foroumadi A; Mirzaei M; Shafiee A
Farmaco; 2001 Aug; 56(8):621-3. PubMed ID: 11601649
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and evaluation of some 1,3,5-triazinyl urea and thiourea derivatives as antimicrobial agents.
Chikhalia KH; Patel MJ
J Enzyme Inhib Med Chem; 2009 Aug; 24(4):960-6. PubMed ID: 19555172
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of new imidazo[2,1-b][1,3,4]thiadiazole-benzimidazole derivatives.
Ramprasad J; Nayak N; Dalimba U; Yogeeswari P; Sriram D; Peethambar SK; Achur R; Kumar HS
Eur J Med Chem; 2015 May; 95():49-63. PubMed ID: 25794789
[TBL] [Abstract][Full Text] [Related]
12. Antimycobacterial activity of novel 1-(5-cyclobutyl-1,3-oxazol-2-yl)-3-(sub)phenyl/pyridylthiourea compounds endowed with high activity toward multidrug-resistant Mycobacterium tuberculosis.
Sriram D; Yogeeswari P; Dinakaran M; Thirumurugan R
J Antimicrob Chemother; 2007 Jun; 59(6):1194-6. PubMed ID: 17449482
[TBL] [Abstract][Full Text] [Related]
13. Design, development, drug-likeness, and molecular docking studies of novel piperidin-4-imine derivatives as antitubercular agents.
Revathi R; Venkatesha Perumal R; Pai KS; Arunkumar G; Sriram D; Kini SG
Drug Des Devel Ther; 2015; 9():3779-87. PubMed ID: 26229439
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, and Molecular Docking Study of Novel Heterocycles Incorporating 1,3,4-Thiadiazole Moiety as Potential Antimicrobial and Anticancer Agents.
El-Naggar M; Sallam HA; Shaban SS; Abdel-Wahab SS; E Amr AE; Azab ME; Nossier ES; Al-Omar MA
Molecules; 2019 Mar; 24(6):. PubMed ID: 30889918
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, in vitro-antimycobacterial activity and cytotoxicity of some alkyl alpha-(5-aryl-1, 3, 4-thiadiazole-2-ylthio)acetates.
Foroumadi A; Soltani F; Moallemzadeh-Haghighi H; Shafiee A
Arch Pharm (Weinheim); 2005 Mar; 338(2-3):112-6. PubMed ID: 15756694
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, SAR and Molecular Modeling Studies of Novel Imidazo[2,1-b][1,3,4]Thiadiazole Derivatives as Highly Potent Antimicrobial Agents.
Tahtaci H; Karacık H; Ece A; Er M; Şeker MG
Mol Inform; 2018 Mar; 37(3):. PubMed ID: 28876536
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Anticancer Activity of Thiadiazole Containing Thiourea, Benzothiazole and Imidazo[2,1-b][1,3,4]thiadiazole Scaffolds.
Avvaru SP; Noolvi MN; More UA; Chakraborty S; Dash A; Aminabhavi TM; Narayan KP; Sutariya V
Med Chem; 2021; 17(7):750-765. PubMed ID: 32427086
[TBL] [Abstract][Full Text] [Related]
18. Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating Mycobacterium tuberculosis.
Karabanovich G; Zemanová J; Smutný T; Székely R; Šarkan M; Centárová I; Vocat A; Pávková I; Čonka P; Němeček J; Stolaříková J; Vejsová M; Vávrová K; Klimešová V; Hrabálek A; Pávek P; Cole ST; Mikušová K; Roh J
J Med Chem; 2016 Mar; 59(6):2362-80. PubMed ID: 26948407
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antimicrobial activity of some 2,5-disubstituted 1,3,4,-thiadiazole derivatives.
Mamolo MG; Vio L; Banfi E
Farmaco; 1996 Jan; 51(1):71-4. PubMed ID: 8721765
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, Pharmacological Evaluation, In silico Modeling, Prediction of Toxicity and Metabolism Studies of Novel 1-(substituted)-2-methyl- 3-(4-oxo-2-phenyl quinazolin-3(4H)-yl)isothioureas.
Sulthana MT; Alagarsamy V; Chitra K
Med Chem; 2021; 17(4):352-368. PubMed ID: 32807063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
